Drug
Gc4006a
Gc4006a: highest development phase Phase 2, developed by GC Biopharma Corp. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- GC Biopharma Corp
Trials
| Drug | Phase | Indication |
|---|---|---|
| GC4006A NCT07936188 | Phase 2 | Covid-19 Prevention |
Latest
No recent events.
Follow Gc4006a on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.